173 related articles for article (PubMed ID: 29064628)
21. [Solutions for off-label therapy].
Schmidt WA
Z Rheumatol; 2003; 62(Suppl 2):II54-6. PubMed ID: 14648094
[TBL] [Abstract][Full Text] [Related]
22. [Legally billing autologous hemotherapy].
Zimmermann GW
MMW Fortschr Med; 2016 May; 158(9):22. PubMed ID: 27155685
[No Abstract] [Full Text] [Related]
23. [Services automatically granted after 3 weeks].
Mwo
MMW Fortschr Med; 2016 Mar; 158(6):41. PubMed ID: 27084153
[No Abstract] [Full Text] [Related]
24. [IGeL - a questionable debate].
Schaefer C
Z Evid Fortbild Qual Gesundhwes; 2012; 106(7):540-1. PubMed ID: 22981030
[No Abstract] [Full Text] [Related]
25. [10 topic paper of the BDK on the new payment system in psychiatry and psychotherapy].
Psychiatr Prax; 2011 Feb; 38(2):104-7. PubMed ID: 21394696
[No Abstract] [Full Text] [Related]
26. [Is the physician the insurance broker for his patients?].
Wienke A; Sailer R
Laryngorhinootologie; 2013 Dec; 92(12):834-5. PubMed ID: 24285207
[No Abstract] [Full Text] [Related]
27. Association of Supporting Trial Evidence and Reimbursement for Off-Label Use of Cancer Drugs.
Herbrand AK; Schmitt AM; Briel M; Ewald H; Goldkuhle M; Diem S; Hoogkamer A; Joerger M; Moffa G; Novak U; Hemkens LG; Kasenda B
JAMA Netw Open; 2021 Mar; 4(3):e210380. PubMed ID: 33651108
[TBL] [Abstract][Full Text] [Related]
28. Contrasting evidence to reimbursement reality for off-label use (OLU) of drug treatments in cancer care: rationale and design of the CEIT-OLU project.
Herbrand AK; Schmitt AM; Briel M; Diem S; Ewald H; Hoogkamer A; Joerger M; Mc Cord KA; Novak U; Sricharoenchai S; Hemkens LG; Kasenda B
ESMO Open; 2019; 4(6):e000596. PubMed ID: 31803503
[TBL] [Abstract][Full Text] [Related]
29. [Cannabis in medicine. Legal aspects].
Wartensleben H
Schmerz; 2004 Dec; 18 Suppl 2():S34-5. PubMed ID: 23570089
[No Abstract] [Full Text] [Related]
30. [Agreement on elective procedures in unconscious (emergency) patients].
Heberer J; Mischkowsky T
Chirurg; 2001 Jul; 72(7):suppl 183-4. PubMed ID: 11490770
[No Abstract] [Full Text] [Related]
31. [Active contract physicians are liable for recourse claims of "passive" contract physicians].
Zimmerman GW
MMW Fortschr Med; 2013 Oct; 155(17):13. PubMed ID: 24340369
[No Abstract] [Full Text] [Related]
32. [Legal decisions of german supreme courts about prescription of drugs for not registered indications ("off-label-use")].
Wetterling T
Fortschr Neurol Psychiatr; 2004 May; 72(5):255-9. PubMed ID: 15136946
[TBL] [Abstract][Full Text] [Related]
33. [Leflunomide and TNF inhibitors. Experiences from precription recourse proceedings].
Brandt-Jürgens J
Z Rheumatol; 2013 Mar; 72(2):114-6. PubMed ID: 23223912
[No Abstract] [Full Text] [Related]
34. [The physician caught between two chairs. Comments on the difficulty in dealing with off-label use].
Harder Yv
Urologe A; 2007 Oct; 46(10):1429-34. PubMed ID: 17786403
[No Abstract] [Full Text] [Related]
35. Routine skin cancer screening in Germany: First data on the impact on health care in dermatology.
Augustin M; Blome C; Rustenbach SJ; Reusch M; Radtke M
J Dtsch Dermatol Ges; 2010 Sep; 8(9):674-80. PubMed ID: 20529170
[TBL] [Abstract][Full Text] [Related]
36. [Off-label use in oncology: an inexhaustible topic?!].
Weissbach L; Riese J
Urologe A; 2006 Nov; 45(11):1410, 1412-4. PubMed ID: 17043888
[TBL] [Abstract][Full Text] [Related]
37. [The new EBM confuses family practitioners. No. 03120 not covered in chronic disease entities].
MMW Fortschr Med; 2005 May; 147(20):45-6. PubMed ID: 15957861
[No Abstract] [Full Text] [Related]
38. Pharmacoepidemiology of testosterone: Impact of reimbursement policy on curbing off-label prescribing.
Handelsman DJ
Pharmacoepidemiol Drug Saf; 2020 Sep; 29(9):1030-1036. PubMed ID: 32743911
[TBL] [Abstract][Full Text] [Related]
39. [Can structured dialogue get the debate on the PEPP-system moving? - A ray of hope for psychiatric hospital treatment of children and adolescents?].
Schepker R; Fegert JM
Z Kinder Jugendpsychiatr Psychother; 2015 Nov; 43(6):377-9. PubMed ID: 26602041
[No Abstract] [Full Text] [Related]
40. [The rheumatologist's conflict between "off-label" prescription and failure to render assistance].
Hellmich B; Gross WL
Z Rheumatol; 2003 Feb; 62(1):34-5. PubMed ID: 12624800
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
